Showing results (71-80 of 1,033) with videos related to

Sort By:
Pageof 104
European Heart Journal|June 22, 2023
Personalised antiplatelet therapies for coronary artery disease: what the future holdsDavide Capodanno, Dominick J Angiolillo
JACC. Cardiovascular Interventions|January 4, 2023
Timing, Selection, Modulation, and Duration of P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCIDavide Capodanno, Dominick J Angiolillo
Interventional Cardiology Clinics|November 26, 2016
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs?Davide Capodanno, Dominick J Angiolillo
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 19, 2016
Upcoming TAVI trials: rationale, design and impact on clinical practiceDavide Capodanno, Martin B Leon
Expert Opinion on Biological Therapy|December 22, 2017
Canakinumab for secondary prevention of atherosclerotic diseaseDavide Capodanno, Dominick J Angiolillo
The American Journal of Cardiology|March 12, 2021
Aspirin for Primary Prevention of Cardiovascular Disease in the 21st Century: A Review of the EvidenceDominick J Angiolillo, Davide Capodanno
Circulation|October 13, 2016
Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes MellitusDavide Capodanno, Dominick J Angiolillo
Pageof 104